Greenwich LifeSciences In... (GLSI)
NASDAQ: GLSI
· Real-Time Price · USD
12.11
0.03 (0.25%)
At close: Aug 15, 2025, 3:59 PM
12.17
0.50%
After-hours: Aug 15, 2025, 07:26 PM EDT
Greenwich LifeSciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.26M | -8.04M | -2.67M | -2.61M | -2.47M | -2.75M | -2.39M | -1.63M | -2.12M | -2.79M | -2.32M | -746.07K | -1.97M | -2.36M | -863.12K | -749.75K | -597.01K |
Depreciation & Amortization | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 |
Stock-Based Compensation | 1.54M | 5.47M | 594.52K | 594.52K | 594.52K | 594.52K | 594.52K | 594.52K | 594.52K | 594.52K | 759.57K | 224.5K | 165.27K | 165.43K | 165.05K | 165.05K | 165.05K |
Other Working Capital | 8.45K | 314.57K | 49.83K | -25.23K | 4.94K | -28.3K | 65.3K | 65.97K | -27.33K | 25.03K | 8.74K | -12.03K | -144K | 5.05K | 134.26K | -20.53K | 22.78K |
Other Non-Cash Items | n/a | n/a | n/a | n/a | 506.06K | 570.91K | 596.33K | 596.33K | 596.33K | 596.33K | 761.38K | 226.31K | 167.07K | 2.21M | 498.59K | 166.86K | 286.86K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -570.91K | -596.33K | -596.33K | -596.33K | -596.33K | -761.38K | -226.31K | n/a | -2.21M | n/a | n/a | n/a |
Change in Working Capital | -121.21K | 717.35K | -510.64K | 963.42K | 95.2K | -2.88K | -4.26K | 65.97K | -27.33K | 25.03K | 8.74K | -12.03K | -144K | -69.95K | -197.47K | -20.53K | -97.22K |
Operating Cash Flow | -1.83M | -1.85M | -2.58M | -1.05M | -1.78M | -2.15M | -1.8M | -966.98K | -1.56M | -2.17M | -1.55M | -532.7K | -1.95M | -2.26M | -894.64K | -604.32K | -528.27K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.54M | n/a | -2.02M | -5.51M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 1.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -275.15K |
Financial Cash Flow | 492.42K | 121.83K | 1.18M | 2.77M | 299.12K | n/a | n/a | n/a | n/a | -7.54M | n/a | -2.02M | -5.51M | 562.6K | n/a | n/a | 2.27M |
Net Cash Flow | -1.34M | -1.73M | -1.4M | 1.72M | -1.48M | -2.15M | -1.8M | -966.98K | -1.56M | -2.17M | -1.55M | -2.56M | -7.46M | -1.7M | -894.64K | -604.32K | 1.74M |
Free Cash Flow | -1.83M | -1.85M | -2.58M | -1.05M | -1.78M | -2.15M | -1.8M | -966.98K | -1.56M | -2.17M | -1.55M | -532.7K | -1.95M | -2.26M | -894.64K | -604.32K | -528.27K |